BIOMAT Database Logo BIOMAT Database Logo

Prognostic relevance of morphological classification in multiple myeloma. 1992

H Murakami, and K Nemoto, and M Sawamura, and J Tamura, and T Matsushima, and T Naruse, and J Tsuchiya, and S Sato, and S Shiamano, and S Shinonome
Third Department of Internal Medicine, Gunma University School of Medicine, Japan.

One hundred and twenty-two patients with multiple myeloma were classified as mature, intermediate, immature, or plasmablastic subtype according to Greipp's criteria. Contrary to Greipp's report, the survival time of plasmablastic myeloma was not significantly shorter than other subtypes, nor was the plasmablastic subtype identified as a poor prognostic factor. The survival time of mature plus intermediate myeloma was significantly longer than that of immature plus plasmablastic myeloma. Between the former and latter, significant differences were found for sex, clinical stage, thrombocytopenia, bone marrow plasmacytosis, renal insufficiency, bone destruction, and response rate to treatment. Therefore, it was suspected that the immature and plasmablastic subtypes were unfavorable prognostic factors in patients with multiple myeloma.

UI MeSH Term Description Entries
D007132 Immunoglobulin Isotypes The classes of immunoglobulins found in any species of animal. In man there are nine classes that migrate in five different groups in electrophoresis; they each consist of two light and two heavy protein chains, and each group has distinguishing structural and functional properties. Antibody Class,Ig Isotype,Ig Isotypes,Immunoglobulin Class,Immunoglobulin Isotype,Antibody Classes,Immunoglobulin Classes,Class, Antibody,Class, Immunoglobulin,Classes, Antibody,Classes, Immunoglobulin,Isotype, Ig,Isotype, Immunoglobulin,Isotypes, Ig,Isotypes, Immunoglobulin
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009101 Multiple Myeloma A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY. Myeloma, Plasma-Cell,Kahler Disease,Myeloma, Multiple,Myeloma-Multiple,Myelomatosis,Plasma Cell Myeloma,Cell Myeloma, Plasma,Cell Myelomas, Plasma,Disease, Kahler,Multiple Myelomas,Myeloma Multiple,Myeloma, Plasma Cell,Myeloma-Multiples,Myelomas, Multiple,Myelomas, Plasma Cell,Myelomas, Plasma-Cell,Myelomatoses,Plasma Cell Myelomas,Plasma-Cell Myeloma,Plasma-Cell Myelomas
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D003953 Diagnosis-Related Groups A system for classifying patient care by relating common characteristics such as diagnosis, treatment, and age to an expected consumption of hospital resources and length of stay. Its purpose is to provide a framework for specifying case mix and to reduce hospital costs and reimbursements and it forms the cornerstone of the prospective payment system. Case Mix,DRG,Diagnosis Related Group,Diagnosis-Related Group,Case Mixes,DRGs,Diagnostic-Related Group,Group, Diagnostic-Related,Groups, Diagnostic-Related,Diagnosis Related Groups,Diagnostic Related Group,Diagnostic-Related Groups,Group, Diagnosis Related,Group, Diagnosis-Related,Group, Diagnostic Related,Groups, Diagnosis Related,Groups, Diagnosis-Related,Groups, Diagnostic Related,Related Group, Diagnosis,Related Groups, Diagnosis
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D012737 Sex Factors Maleness or femaleness as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or effect of a circumstance. It is used with human or animal concepts but should be differentiated from SEX CHARACTERISTICS, anatomical or physiological manifestations of sex, and from SEX DISTRIBUTION, the number of males and females in given circumstances. Factor, Sex,Factors, Sex,Sex Factor

Related Publications

H Murakami, and K Nemoto, and M Sawamura, and J Tamura, and T Matsushima, and T Naruse, and J Tsuchiya, and S Sato, and S Shiamano, and S Shinonome
[Prognostic clinical and morphological classification of multiple myeloma (author's transl)].
January 1979, Archiv fur Geschwulstforschung,
H Murakami, and K Nemoto, and M Sawamura, and J Tamura, and T Matsushima, and T Naruse, and J Tsuchiya, and S Sato, and S Shiamano, and S Shinonome
Prognostic relevance of cellular morphology in multiple myeloma.
May 1984, Blood,
H Murakami, and K Nemoto, and M Sawamura, and J Tamura, and T Matsushima, and T Naruse, and J Tsuchiya, and S Sato, and S Shiamano, and S Shinonome
Prognostic factors and classification in multiple myeloma.
January 1989, British journal of cancer,
H Murakami, and K Nemoto, and M Sawamura, and J Tamura, and T Matsushima, and T Naruse, and J Tsuchiya, and S Sato, and S Shiamano, and S Shinonome
Multiple myeloma: significance of plasmablastic subtype in morphological classification.
February 1985, Blood,
H Murakami, and K Nemoto, and M Sawamura, and J Tamura, and T Matsushima, and T Naruse, and J Tsuchiya, and S Sato, and S Shiamano, and S Shinonome
FGFR3 dysregulation in multiple myeloma: frequency and prognostic relevance.
June 2002, British journal of haematology,
H Murakami, and K Nemoto, and M Sawamura, and J Tamura, and T Matsushima, and T Naruse, and J Tsuchiya, and S Sato, and S Shiamano, and S Shinonome
[Classification, staging and prognostic indices for multiple myeloma].
December 2007, Nihon rinsho. Japanese journal of clinical medicine,
H Murakami, and K Nemoto, and M Sawamura, and J Tamura, and T Matsushima, and T Naruse, and J Tsuchiya, and S Sato, and S Shiamano, and S Shinonome
Frequency and prognostic relevance of cyclin D1 dysregulation in multiple myeloma.
January 2001, European journal of haematology,
H Murakami, and K Nemoto, and M Sawamura, and J Tamura, and T Matsushima, and T Naruse, and J Tsuchiya, and S Sato, and S Shiamano, and S Shinonome
[Prognostic evaluation in multiple myeloma. Relationship between immunological types, single prognostic factors, clinical staging systems, morphological classification systems and survival].
January 1990, Annali italiani di medicina interna : organo ufficiale della Societa italiana di medicina interna,
H Murakami, and K Nemoto, and M Sawamura, and J Tamura, and T Matsushima, and T Naruse, and J Tsuchiya, and S Sato, and S Shiamano, and S Shinonome
Prognostic significance of morphological assessment of plasma cells in multiple myeloma.
January 2011, Neoplasma,
H Murakami, and K Nemoto, and M Sawamura, and J Tamura, and T Matsushima, and T Naruse, and J Tsuchiya, and S Sato, and S Shiamano, and S Shinonome
[Usefulness of the modified Greipp's morphological classification of multiple myeloma cells].
December 1996, Rinsho byori. The Japanese journal of clinical pathology,
Copied contents to your clipboard!